These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10249528)

  • 1. Protection of human subjects; informed consent--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(17 pt 2):8942-58. PubMed ID: 10249528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of human subjects; standards for institutional review boards for clinical investigations--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(17 pt 2):8958-79. PubMed ID: 10249529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Proposed rule.
    Fed Regist; 1988 Nov; 53(218):45678-82. PubMed ID: 10290533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of human subjects; informed consent; correction. Food and Drug Administration. Final rule; correction.
    Fed Regist; 1982 Feb; 47(31):6617-8. PubMed ID: 10298463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of human subjects; informed consent; standards for institutional review boards for clinical investigations--FDA. Final rule.
    Fed Regist; 1991 Jun; 56(117):28025-9. PubMed ID: 10112215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of human subjects; informed consent--FDA. Final rule.
    Fed Regist; 1996 Oct; 61(192):51498-533. PubMed ID: 10161558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human drugs and biologics; determination that informed consent is NOT feasible or is contrary to the best interests of recipients; revocation of 1990 interim final rule; establishment of new interim final rule. Food and Drug Administration, HHS. Interim final rule; opportunity for public comment.
    Fed Regist; 1999 Oct; 64(192):54180-9. PubMed ID: 11010702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigational new drug application; exception from informed consent; technical amendment--FDA. Final rule.
    Fed Regist; 1997 Jun; 62(115):32479. PubMed ID: 10169828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New bill of rights for human volunteers.
    FDA Consum; 1979 Dec-1980 Jan; 13(10):24-5. PubMed ID: 10309107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informed consent elements. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2011 Jan; 76(2):256-70. PubMed ID: 21261126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Researcher liability for negligence in human subject research: informed consent and researcher malpractice actions.
    Jansson RL
    Wash Law Rev; 2003 Feb; 78(1):229-63. PubMed ID: 15732212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA overview and current challenges in regulation of human subject protection. Food and Drug Administration.
    Nightingale SL
    J Int Assoc Physicians AIDS Care; 1997 Jan; 3(1):24-6. PubMed ID: 11363959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA's emergency research rule: an inch given, a yard taken.
    Gillenwater GE
    Food Drug Law J; 2008; 63(1):217-56. PubMed ID: 18561460
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection of human subjects; prisoners used as subjects in research; stay of effective date--Food and Drug Administration. Final rule; stay of effective date.
    Fed Regist; 1981 Jul; 46(129):35085. PubMed ID: 10251918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Food and Drug Administration and pragmatic clinical trials of marketed medical products.
    Anderson ML; Griffin J; Goldkind SF; Zeitler EP; Wing L; Al-Khatib SM; Sherman RE
    Clin Trials; 2015 Oct; 12(5):511-9. PubMed ID: 26374684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigational new drug applications; clinical holds--FDA. Direct final rule.
    Fed Regist; 1998 Dec; 63(239):68676-8. PubMed ID: 10187558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical devices; exception from general requirements for informed consent. Interim final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jun; 71(109):32827-34. PubMed ID: 16795934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 1999 May; 64(93):26282-7. PubMed ID: 10558530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of clinical investigations; availability of guideline--FDA. Notice.
    Fed Regist; 1988 Feb; 53(31):4723-4. PubMed ID: 10285639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it time to abandon FDA's no release from liability regulation for clinical studies?
    Winter JD
    Food Drug Law J; 2008; 63(2):525-36. PubMed ID: 18561476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.